SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001524829-19-000007
Filing Date
2019-04-17
Accepted
2019-04-17 10:35:34
Documents
42
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 qbio10q.htm 10-Q 294650
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO ex_31-1.htm EX-31.1 12832
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex_32-1.htm EX-32.1 5267
  Complete submission text file 0001524829-19-000007.txt   1301281

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE qbio-20190228.xml EX-101.INS 178555
5 XBRL SCHEMA FILE qbio-20190228.xsd EX-101.SCH 18335
6 XBRL CALCULATION FILE qbio-20190228_cal.xml EX-101.CAL 25049
7 XBRL DEFINITION FILE qbio-20190228_def.xml EX-101.DEF 23259
8 XBRL LABEL FILE qbio-20190228_lab.xml EX-101.LAB 106017
9 XBRL PRESENTATION FILE qbio-20190228_pre.xml EX-101.PRE 82357
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 19752431
SIC: 2834 Pharmaceutical Preparations